title: Hemodynamic effects of partial correction of chronic anemia by recombinant human erythropoietin in patients on dialysis.
abstract: Eighteen patients on chronic hemodialysis with renal anemia were treated with recombinant human erythropoietin (r-HuEPO). Hemodynamic parameters in the resting state were determined before and after successful treatment. Posttreatment cardiac index was decreased (3.3 v 2.8 L/min/m2), whereas diastolic blood pressure (72 v 79 mm Hg) and calculated peripheral resistance (2,230 v 2,860 dyne.cm.s-5) were increased significantly when compared with the pretreatment period. We conclude from our study that the increase of blood pressure as seen in patients on dialysis, who are effectively treated with r-HuEPO, is due to an increase in peripheral resistance. This increase overrules the decrease of cardiac index and might well be a result of peripheral vasoconstriction due to improved oxygen availability.
authors.affiliation: Second Department of Internal Medicine, University of Vienna, Austria.
authors.forename: G
authors.initials: G
authors.lastname: Mayer
authors.forename: E M
authors.initials: EM
authors.lastname: Cada
authors.forename: U
authors.initials: U
authors.lastname: Watzinger
authors.forename: U
authors.initials: U
authors.lastname: Barnas
authors.forename: H
authors.initials: H
authors.lastname: Graf
mesh_terms: D000328:Adult; D000747:Anemia, Hypochromic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D002908:Chronic Disease; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007022:Hypotension / Q000503:physiopathology; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin